Skip to main content

Search

Reset all filters
136 Result(s)
Sort by

Commits to Thoracic Society’s COVID-19 Fund

Commits to Thoracic Society’s COVID-19 Fund

Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
Rare Diseases: Rare but not alone

Rare Diseases: Rare but not alone

We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Obesity osteoarthritis in pets a blind spot

Obesity osteoarthritis in pets a blind spot

Body weight is just one indicator among many when it comes to a pet’s health status, but there are some diseases associated with it. Learn more here.
3 scopes for sustainability Saint Vulbas France

3 scopes for sustainability Saint Vulbas France

Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
Expectations towards our business partners

Expectations towards our business partners

Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
Patient Documentary

Patient Documentary

People with type 2 diabetes are two to four times more likely to develop heart disease compared with people without diabetes
COVID-19 Volunteering in the U.S.

COVID-19 Volunteering in the U.S.

BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Innovation Through Cooperation

Innovation Through Cooperation

Exchange of information between pharmaceutical manufacturers and healthcare professionals is essential for patients. Click here to learn more.
Interview: Excellence in stem cell treatments

Interview: Excellence in stem cell treatments

Acquisition of GST reflects the enormous potential of biotechnology research to provide breakthrough therapies for major diseases. Learn more.
Women in STEM 2022

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Stroke Risk Factors Symptoms

Stroke Risk Factors Symptoms

Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Find out more about risk factors and symptoms.
Poultry farming drives sustainability

Poultry farming drives sustainability

The Village Poultry Project & Making More Health strive to make poultry farming sustainable. Click here to find out more information about this.
1948-1988

1948-1988

Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.
Circular economy towards the future

Circular economy towards the future

Boehringer Ingelheim uses eco-design to shape and develop animal health products with an improved environmental profile. Click here to read more.